CD8A and neoplasm: It was also shown that patients with non-miliary tumor spread present with an increased adaptive immune reaction (e.g., CD8+ immune cell tumor infiltration) and immune-checkpoint expression (e.g., PD-L1 on tumor cells) [7], therefore might render good candidates for an additional immune therapy.